Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Imamura

Showing results (341-350 of 395) with videos related to

Pageof 40
Sort By:
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 1, 1996
[Peripheral lymphocyte subset of patients with pancreatic diabetes mellitus--about a decreased ratio of T-LGL and ability of host defense]M Tsujino, I Kinpara, T Nakamura, et al.
Modern Rheumatology|June 13, 2014
Efficient diagnosis of Sjögren's syndrome to reduce the burden on patientsAsumi J Niikura, Shigeo Yamachika, Ken Yamamoto, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|November 22, 2023
The effect of nano hydroxyapatite coating implant surfaces on gene expression and osseointegrationH Kasai, E-T Bergamo, Í-D Balderrama, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2025
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancerTakehiko Sambe, Chiyo K Imamura, Noriko Hida, et al.
Cancer Biology & Therapy|September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumorsNilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Journal of Microbiological Methods|July 11, 2015
Evaluation of a novel immunochromatographic device for rapid and accurate clinical detection of Porphyromonas gingivalis in subgingival plaqueK Imamura, S Takayama, A Saito, et al.
Cancer Chemotherapy and Pharmacology|February 11, 2020
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicityTakahisa Kawamura, Chiyo K Imamura, Hirotsugu Kenmotsu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 26, 2015
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic studyEisuke Booka, Chiyo K Imamura, Hiroya Takeuchi, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patientsHirotsugu Kenmotsu, Chiyo K Imamura, Takahisa Kawamura, et al.
BMJ Open|April 3, 2023
Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B)Hitomi Sakai, Junji Tsurutani, Yukinori Ozaki, et al.
Pageof 40

Showing results (341-350 of 395) with videos related to

Sort By:
Pageof 40
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 1, 1996
[Peripheral lymphocyte subset of patients with pancreatic diabetes mellitus--about a decreased ratio of T-LGL and ability of host defense]M Tsujino, I Kinpara, T Nakamura, et al.
Modern Rheumatology|June 13, 2014
Efficient diagnosis of Sjögren's syndrome to reduce the burden on patientsAsumi J Niikura, Shigeo Yamachika, Ken Yamamoto, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|November 22, 2023
The effect of nano hydroxyapatite coating implant surfaces on gene expression and osseointegrationH Kasai, E-T Bergamo, Í-D Balderrama, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2025
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancerTakehiko Sambe, Chiyo K Imamura, Noriko Hida, et al.
Cancer Biology & Therapy|September 10, 2009
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumorsNilofer Azad, Alyssa Perroy, Erin Gardner, et al.
Journal of Microbiological Methods|July 11, 2015
Evaluation of a novel immunochromatographic device for rapid and accurate clinical detection of Porphyromonas gingivalis in subgingival plaqueK Imamura, S Takayama, A Saito, et al.
Cancer Chemotherapy and Pharmacology|February 11, 2020
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicityTakahisa Kawamura, Chiyo K Imamura, Hirotsugu Kenmotsu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 26, 2015
Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic studyEisuke Booka, Chiyo K Imamura, Hiroya Takeuchi, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2022
Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patientsHirotsugu Kenmotsu, Chiyo K Imamura, Takahisa Kawamura, et al.
BMJ Open|April 3, 2023
Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B)Hitomi Sakai, Junji Tsurutani, Yukinori Ozaki, et al.
Pageof 40